Table 3.

Presentation of Inpatient Cases of Definite Cholangitis Among Patients With ADPKD-Associated PLD^a,b

Presentation	No. of patients	Value
Symptoms/signs
Fever/chills, No. (%)	11	11 (100.0)
Jaundice, No. (%)	11	0 (0.00)
Imaging
Biliary dilatation, No. (%)	11	6 (54.5)
Gallstones, No. (%)	11	8 (72.7)
CKD stage, No. (%)	11
1		0 (0.00)
2		2 (18.2)
3A		3 (27.3)
3B		4 (36.4)
4		1 (9.1)
5		1 (9.1)
Laboratory valuesc
Elevated WBC/CRP, No. (%)	11	8 (72.7)
Total bilirubin (mg/dL)	10	1.6±1.4
Direct bilirubin (mg/dL)	8	1.2±1.3
Lactate (mmol/L)	6	1.6±1.2
INR	7	1.5±0.5
Creatinine (mg/dL)	11	1.6±0.8
Albumin (g/dL)	9	3.5±0.8
ALP (IU/L)	11	223.1±109.6
AST (IU/L)	10	161.2±220.1
ALT (2IU/L)	9	118.3±121.3

^aADPKD = autosomal dominant polycystic kidney disease; ALP = alkaline phosphatase; ALT = alanine aminotransferase; AST = aspartate aminotransferase; CKD = chronic kidney disease; CRP = C-reactive protein; INR = international normalized ratio; PLD = polycystic liver disease; WBC = white blood cell count.

^bSI conversion factors: To convert total and direct bilirubin values to μmol/L, multiply by 17.104; to convert creatinine value to μmol/L, multiply by 88.4; to convert albumin value to g/L, multiply by 10; to convert ALP and ALT values to μkat/L, multiply by 0.0167; to convert AST value to μkat/L, multiply by 0.01667.

^cLaboratory values are presented as mean ± SD unless indicated otherwise.